Liangyu Lin

3.2k total citations · 2 hit papers
24 papers, 2.3k citations indexed

About

Liangyu Lin is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Liangyu Lin has authored 24 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Genetics and 10 papers in Oncology. Recurrent topics in Liangyu Lin's work include Mesenchymal stem cell research (10 papers), Immune cells in cancer (9 papers) and Cancer Cells and Metastasis (5 papers). Liangyu Lin is often cited by papers focused on Mesenchymal stem cell research (10 papers), Immune cells in cancer (9 papers) and Cancer Cells and Metastasis (5 papers). Liangyu Lin collaborates with scholars based in China, Italy and United States. Liangyu Lin's co-authors include Yufang Shi, Ying Wang, Liming Du, Pengfei Yu, Guohong Hu, Yin Huang, Xueqian Zhuang, Fei Chen, Yu Sun and Yuping Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Reviews Drug Discovery.

In The Last Decade

Liangyu Lin

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New horizons in tumor microenvironment biology: challenges and opportunities

2015 545 citations Liangyu Lin, Pengfei Yu et al. profile →
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets

2016 373 citations Yufang Shi, Liming Du et al. Nature Reviews Drug Discovery profile →

Peers

Liangyu Lin

MB

ONCOL

IMMUN

GENET

CR

Hernan Roca United States

Shu‐Ching Hsu Taiwan

Claudia A. Dumitru Germany

Keisuke Kataoka Japan

Claudia Giachino Italy

Stefaan Van Gool Belgium

Bin Pan China

Yi Tang United States

W. Nathaniel Brennen United States

Xiaohong Yao China

Hernan Roca United States

Liangyu Lin

1.2k ×1.3

MB

850 ×1.1

ONCOL

779 ×1.1

IMMUN

182 ×0.3

GENET

350 ×0.7

CR

Citations per year, relative to Liangyu Lin Liangyu Lin (= 1×) peers Hernan Roca

Countries citing papers authored by Liangyu Lin

Since Specialization

Citations

This map shows the geographic impact of Liangyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangyu Lin more than expected).

Fields of papers citing papers by Liangyu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangyu Lin. The network helps show where Liangyu Lin may publish in the future.

Co-authorship network of co-authors of Liangyu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liangyu Lin. A scholar is included among the top collaborators of Liangyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangyu Lin. Liangyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lin, Liangyu, et al.. (2025). Application of mitochondrial genomes to species identification and evolution. Electronic Journal of Biotechnology. 76. 39–48. 3 indexed citations

2.

Yao, S.Z., Huan Yang, Qiuming Zeng, et al.. (2025). Chimeric Antigen Receptor T‐Cell Therapy and Autoimmune Diseases in the Nervous System. Immunity Inflammation and Disease. 13(11). e70298–e70298.

3.

Wang, Yu, Xiaoxiao Li, Xuefeng Wang, et al.. (2023). Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer. Nature Metabolism. 5(8). 1408–1422. 24 indexed citations

4.

Wang, Xuefeng, Yu Chen, Bin Lan, et al.. (2022). Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells. Theranostics. 12(5). 2063–2079. 12 indexed citations

5.

Zhang, Tao, Yu Wang, Qing Li, et al.. (2022). Mesenchymal stromal cells equipped by IFNα empower T cells with potent anti-tumor immunity. Oncogene. 41(13). 1866–1881. 14 indexed citations

6.

Zhang, Tao, Xiaohong Chen, Wei Cao, et al.. (2021). Steroids Enable Mesenchymal Stromal Cells to Promote CD8⁺ T Cell Proliferation Via VEGF‐C. Advanced Science. 8(12). 2003712–2003712. 11 indexed citations

7.

Lin, Liangyu, Li Q, Ying Wang, & Yufang Shi. (2021). Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death and Differentiation. 28(6). 2019–2021. 58 indexed citations

8.

Wang, Xuefeng, Liangyu Lin, Bin Lan, et al.. (2020). IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages. Science Advances. 6(48). 43 indexed citations

9.

Huang, Yin, Qing Li, Kunshan Zhang, et al.. (2019). Single cell transcriptomic analysis of human mesenchymal stem cells reveals limited heterogeneity. Cell Death and Disease. 10(5). 368–368. 77 indexed citations

10.

Du, Liming, Liangyu Lin, Qing Li, et al.. (2019). IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties. Cell Metabolism. 29(6). 1363–1375.e8. 141 indexed citations

11.

Lin, Liangyu & Liming Du. (2017). The role of secreted factors in stem cells-mediated immune regulation. Cellular Immunology. 326. 24–32. 88 indexed citations

12.

Yu, Pengfei, Yin Huang, Chenhong Xu, et al.. (2016). Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis. Oncogene. 36(6). 840–849. 72 indexed citations

13.

Lin, Liangyu, Liming Du, Kai Cao, et al.. (2016). Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities. Oncogene. 35(46). 6038–6042. 71 indexed citations

14.

Yang, Qian, Changwen Zheng, Junjie Cao, et al.. (2016). Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages. Cell Death and Differentiation. 23(11). 1850–1861. 137 indexed citations

15.

Shi, Yufang, Liming Du, Liangyu Lin, & Ying Wang. (2016). Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nature Reviews Drug Discovery. 16(1). 35–52. 373 indexed citations breakdown →

16.

Yu, Pengfei, Yin Huang, Yuping Han, et al.. (2016). TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene. 36(4). 482–490. 185 indexed citations

17.

Han, Xiaoyan, Qin Yang, Liangyu Lin, et al.. (2014). Interleukin-17 enhances immunosuppression by mesenchymal stem cells. Cell Death and Differentiation. 21(11). 1758–1768. 130 indexed citations

18.

Xu, Chunliang, Guangwen Ren, Gang Cao, et al.. (2013). miR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2. Journal of Biological Chemistry. 288(16). 11074–11079. 82 indexed citations

19.

Huang, Yin, Pengfei Yu, Wenzhao Li, et al.. (2013). p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation. Oncogene. 33(29). 3830–3838. 59 indexed citations

20.

Lin, Liangyu, Gang Cao, Qing Chen, et al.. (2013). Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo. Oncogene. 33(42). 5047–5052. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact